Naoki Tarui

CEO
SEEDSUPPLY INC., Japan

Naoki Tarui, Ph.D., is the CEO of SEEDSUPPLY, established in 2017 as a spin-out from Takada Pharmaceutical Company. He specializes in the selection of hit compounds and pursues a more successful drug discovery research process through screening technologies. One of the results is the binder selection technology (BST) gained from his 20 years of small molecule drug discovery research experience at Takeda. His goal to deliver new drugs to patients sooner with efficient drug discovery with BST.

Disclosure information not submitted.

Presentation(s):

• Agile small molecule drug discovery with Binder Selection Technology (BST)

  Tuesday, February 8, 2022
  9:00 AM – 10:00 AM